KLEMP WALTER V bought MBRX
November 4, 2025 · Form 4 insider transaction
KLEMP WALTER V bought 28,750 shares of Moleculin Biotech, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
28,750
Price
N/A
Total value
N/A
InsiderKLEMP WALTER V
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 4, 2025
Filing dateNovember 6, 2025
Shares owned after772,357
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units convert into common stock on a one-for-one basis.